Galapagos | GLPG - Ebit

Stock Price
25.60
Daily Change
-0.34 -1.31%
Monthly
-9.86%
Yearly
15.94%
Q2 Forecast
24.95

Galapagos reported EUR780.56M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
argenx SE USD 371.14M 21.17M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Biogen USD 659.6M 157M Sep/2025
Genmab DKK 260M 199M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
Merck EUR 474M 738M Dec/2025
Neurocrine Biosciences USD 227.9M 11.4M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
UCB EUR 1.29B 571M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025